Davis Lab
Melissa B. Davis, PhD, has published groundbreaking findings that established a new lens to study associations of biological factors in cancer outcomes as related to genetic ancestry. Specifically, she has discovered links between African ancestry and tumor burdens that have a disproportionate burden in people across the African diaspora. Dr. Davis is a pioneer in the field of “disparities genomics,” with specific focus in breast cancer expanding into prostate and gynecological cancers in recent years. Her current findings involve utilizing quantified ancestry to unravel genetic vs environmental influences in tumor biology among race/ethnic groups, including epigenetic cell signaling and immunological responses in the tumor microenvironment and systemic immune regulation.
Melissa B. Davis, PhD
Associate Faculty Member, NYGC
Director, Institute of Translational Genomic Medicine, Morehouse School of Medicine; Scientific Director, International Center for the Study of Breast Cancer Subtypes (ICSBCS); Director of Health Equity, Englander Institute of Precision Medicine; Associate Professor of Cell and Developmental Biology, Weill Cornell Medicine